Q2 2017
Read transcript →Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.16
+0.64%
Mkt Cap $3.01B
Q1 2017
Read transcript →Q4 2016
Read transcript →Q3 2016
Read transcript →Q1 2016
Read transcript →Q4 2015
Read transcript →Q3 2015
Read transcript →Q2 2015
Read transcript →Q1 2015
Read transcript →Q4 2014
Read transcript →Q3 2014
Read transcript →Q2 2014
Read transcript →Q1 2014
Read transcript →Q4 2013
Read transcript →Q3 2013
Read transcript →Q2 2013
Read transcript →Q1 2013
Read transcript →Q4 2012
Read transcript →Q3 2012
Read transcript →Q2 2012
Read transcript →Q2 2010
Read transcript →Q1 2010
Read transcript →Q4 2009
Read transcript →Q3 2009
Read transcript →Q2 2009
Read transcript →Q1 2009
Read transcript →Q4 2008
Read transcript →Q3 2008
Read transcript →Q2 2008
Read transcript →Q1 2008
Read transcript →Q4 2007
Read transcript →Q3 2007
Read transcript →